Parkinson's Disease Clinical Trials in Los Angeles

Showing 21-40 of 133 trials

STEM-PD Open Label Extension (OLE)

NCT04799418

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim148 participantsStarted Sep 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Boca Raton, Florida, United States +12 more locations

RECRUITINGNA< 1 mile

Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation

NCT05307055

This study aims to determine whether direct brain stimulation of specific regions and ranges improves cognition in people with Parkinsons Disease (PD) who already have a deep brain stimulator implanted. Research activities consist of 32 subjects undergoing stimulation changes to their device and being administered neurocognitive tests to evaluate the changes. An fMRI scan will also be done at baseline and at weeks 15 and 27. All subjects will undergo the stimulation changes in a randomized double blind crossover study. Evaluation of stimulation changes will be assessed through analysis of neurocognitive data.

Parkinson Disease

University of Southern California40 participantsStarted Jan 2022

Los Angeles, California, United States

STEM-PD Open Label Extension (OLE)

Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation

Parkinson's Disease Trials in Other Cities

Parkinson's Foundation PD GENEration Genetic Registry

STEM-Parkinson's Disease

North American Prodromal Synucleinopathy Consortium

A Study of TAK-071 in People With Parkinson Disease

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Wearable Assessments in the Clinic and Home in PD

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

Clinical Evaluation of the Infinity Deep Brain Stimulation System

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

Other Conditions in Los Angeles